While the PlexusDx Precision Peptide Genetic Test doesn't assess medication stability itself, it analyzes genetic variants in GIPR (rs1800437), and MC4R (rs17782313) that influence your individual response to GLP-1 therapy
Each dose increase can accelerate weight loss
Today, many non-diabetic patients take GLP-1s to support weight loss , metabolic health, and insulin sensitivity
You met one of Medicares clinical criteria when you first started GLP-1 therapy
It is a powerful antioxidant that neutralizes free radicals and prevents oxidative damage
(44-46) As a word of caution, in some individuals, glutamine can lead to the production of excess glutamate (this can act as an excitatory neurotransmitter and lead to anxiety, insomnia, and headaches)